Filtered By:
Condition: Multiple Sclerosis

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 1656 results found since Jan 2013.

Prediction of falls in subjects suffering from Parkinson ’s disease, multiple sclerosis and stroke
To compare the risk of falls and fall predictors in patients with Parkinson ’s disease (PD), multiple sclerosis (MS) and stroke using the same study design.
Source: Archives of Physical Medicine and Rehabilitation - November 1, 2017 Category: Rehabilitation Authors: Ettore Beghi, Elisa Gervasoni, Elisabetta Pupillo, Elisa Bianchi, Angelo Montesano, Irene Aprile, Michela Agostini, Marco Rovaris, Davide Cattaneo, NEUROFALL Group. Source Type: research

Prediction of falls in subjects suffering from Parkinson's disease, multiple sclerosis and stroke - Beghi E, Gervasoni E, Pupillo E, Bianchi E, Montesano A, Aprile I, Agostini M, Rovaris M, Cattaneo D.
OBJECTIVE: To compare the risk of falls and fall predictors in patients with Parkinson's disease (PD), multiple sclerosis (MS) and stroke using the same study design. DESIGN: Multicenter prospective cohort study. SETTING: Three [masked] institution...
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway Basic Sciences
Conclusions—Our study suggested that FTY720 might be a potential therapeutic drug targeting brain inflammation by skewing microglia toward M2 polarization after chronic cerebral hypoperfusion.
Source: Stroke - November 27, 2017 Category: Neurology Authors: Chuan Qin, Wen-Hui Fan, Qian Liu, Ke Shang, Madhuvika Murugan, Long-Jun Wu, Wei Wang, Dai-Shi Tian Tags: Ischemic Stroke, Vascular Disease Original Contributions Source Type: research

Prediction of Falls in Subjects Suffering From Parkinson Disease, Multiple Sclerosis, and Stroke
To compare the risk of falls and fall predictors in patients with Parkinson disease (PD), multiple sclerosis (MS), and stroke using the same study design.
Source: Archives of Physical Medicine and Rehabilitation - November 1, 2017 Category: Rehabilitation Authors: Ettore Beghi, Elisa Gervasoni, Elisabetta Pupillo, Elisa Bianchi, Angelo Montesano, Irene Aprile, Michela Agostini, Marco Rovaris, Davide Cattaneo, NEUROFALL Group Tags: Original research Source Type: research

Biogen stops testing Tysabri to treat stroke after study fails
(Reuters) - Biogen Inc said on Wednesday it would stop developing its multiple sclerosis drug Tysabri to treat patients with acute ischemic stroke after it failed a mid-stage study.
Source: Reuters: Health - February 7, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Conceptual Underpinnings of the Quality of Life in Neurological Disorders (Neuro-QoL): Comparisons of Core Sets for Stroke, Multiple Sclerosis, Spinal Cord Injury, and Traumatic Brain Injury
To determine the extent to which the content of the Quality of Life in Neurological Disorders (Neuro-QoL) covers the ICF core sets for multiple sclerosis (MS), stroke, spinal cord injury (SCI), and traumatic brain injury (TBI) using summary linkage indicators.
Source: Archives of Physical Medicine and Rehabilitation - April 3, 2018 Category: Rehabilitation Authors: Alex W.K. Wong, Stephen C.L. Lau, Mandy W.M. Fong, David Cella, Jin-Shei Lai, Allen W. Heinemann Source Type: research

Dextromethorphan/Quinidine for Pseudobulbar Affect Following Stroke: Safety and Effectiveness in the PRISM II Trial
Dextromethorphan (DM)/quinidine (Q) was approved for pseudobulbar affect (PBA) treatment based upon efficacy and safety trials in patients with PBA secondary to amyotrophic lateral sclerosis or multiple sclerosis. The PRISM II trial evaluated DM/Q as PBA treatment in patients with stroke, dementia or traumatic brain injury.
Source: PM and R - July 2, 2018 Category: Rehabilitation Authors: Richard D. Zorowitz, David N. Alexander, Andrea E. Formella, Fred Ledon, Charles Davis, Joao Siffert Source Type: research

First look: OhioHealth to open wellness center for stroke, neurological rehabilitation in 2019
OhioHealth is building what it calls a first-of-its-kind fitness and wellness center tailored for patients with stroke, multiple sclerosis and other neurological conditions. Central Ohio's largest health system expects to wrap up a $10 million campaign by year's end for the $12.1 million OhioHealth Neuroscience Wellness Center, which is scheduled to open next year in a wooded area it owns along Olentangy River Road. On Tuesday, OhioHealth released renderings of the design by the Chicago office…
Source: bizjournals.com Health Care:Physician Practices headlines - September 5, 2018 Category: American Health Authors: Carrie Ghose Source Type: news

Dynamic Balance during level walking in patients affected by Multiple Sclerosis, Stroke and Parkinson's disease
Introduction: Balance disorders are a common feature in patients affected by Multiple Sclerosis (MS), Stroke (ST) and Parkinson's disease (PD) generally conditioning their walking ability. These persons adopt a gait strategy that help them preventing falls. Maintaining of this stable gait require balance control, where sensory feedback is integrated to sense the position and the velocity of Center of Mass (CoM) [1]. On the basis of this information a dynamic balance is reached and maintained with appropriated foot placement to stabilize and redirect the CoM.
Source: Gait and Posture - October 1, 2018 Category: Orthopaedics Authors: T. Lencioni, D. Anastasi, I. Carpinella, A. Castagna, A. Crippa, E. Gervasoni, A. Marzegan, M. Rabuffetti, D. Cattaneo, M. Ferrarin Source Type: research

FDA warns about rare but serious risks of stroke and blood vessel wall tears with multiple sclerosis drug Lemtrada (alemtuzumab)
The U.S. Food and Drug Administration (FDA) is warning that rare but serious cases of stroke and tears in the lining of arteries in the head and neck have occurred in patients with multiple sclerosis (MS) shortly after they received Lemtrada (alemtuzumab).
Source: FDA Center for Drug Evaluation and Research - What's New - November 29, 2018 Category: Drugs & Pharmacology Source Type: news

Instrumental Assessment of Stair Ascent in People With Multiple Sclerosis, Stroke, and Parkinson’s Disease: A Wearable-Sensor-Based Approach
Stair ascent is a challenging daily-life activity highly related to independence. This task is usually assessed with clinical scales suffering from partial subjectivity and limited detail in evaluating different task aspects. In this paper, we instrumented the assessment of stair ascent in people with multiple sclerosis (MS), stroke (ST), and Parkinson’s disease (PD) to analyze the validity of the proposed quantitative indexes and characterize subjects’ performances. Participants climbed 10 steps wearing a magneto-inertial sensor [magneto-inertial measurement unit (MIMU)] at sternum level. Gait pattern featur...
Source: IEE Transactions on Neural Systems and Rehabilitation Engineering - December 1, 2018 Category: Neuroscience Source Type: research

Experience of a neurology service during the 2016 Olympic and Paralympic Games
Conclusions As expected, many athletes with sports-related injuries were evaluated, but cases of diverse acute neurologic pathologies were observed among nonathlete members of the OF and PF. Olympic Games are large, logistically complex events involving thousands of people. Our observations suggest that a comprehensive and detailed plan for neurologic emergencies should be considered for future games.
Source: Neurology Clinical Practice - December 10, 2018 Category: Neurology Authors: da Silva, I. R. F., Gouvea, L., Bruno Nogueira, C., Cravo, V., Liberato, B. B. Tags: Medical care, All Cerebrovascular disease/Stroke, Brain trauma, Critical care Research Source Type: research

Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke?
Abstract PMID: 30597511 [PubMed - in process]
Source: Thrombosis and Haemostasis - January 1, 2019 Category: Hematology Authors: Ziliotto N, Zivadinov R, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Ramanathan M, Marchetti G, Bernardi F Tags: Thromb Haemost Source Type: research